Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Strategies to overcome therapeutic resistance in renal cell carcinoma.

Siska PJ, Beckermann KE, Rathmell WK, Haake SM.

Urol Oncol. 2017 Mar;35(3):102-110. doi: 10.1016/j.urolonc.2016.12.002. Epub 2017 Jan 11. Review.


Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?

Haake SM, Rathmell WK.

Cancer. 2017 Jan 1;123(2):200-209. doi: 10.1002/cncr.30314. Epub 2016 Nov 14. Review.


Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.

Haake SM, Weyandt JD, Rathmell WK.

Mol Cancer Res. 2016 Jul;14(7):589-98. doi: 10.1158/1541-7786.MCR-16-0115. Epub 2016 Jun 21. Review.


Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.

Haake SM, Li J, Bai Y, Kinose F, Fang B, Welsh EA, Zent R, Dhillon J, Pow-Sang JM, Chen YA, Koomen JM, Rathmell WK, Fishman M, Haura EB.

Clin Cancer Res. 2016 Nov 15;22(22):5605-5616. doi: 10.1158/1078-0432.CCR-15-1673. Epub 2016 May 24.


Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.

Haake SM, Brooks SA, Welsh E, Fulp WJ, Chen DT, Dhillon J, Haura E, Sexton W, Spiess PE, Pow-Sang J, Rathmell WK, Fishman M.

Urol Oncol. 2016 Mar;34(3):122.e1-7. doi: 10.1016/j.urolonc.2015.09.015. Epub 2015 Nov 3.


Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays.

Smith MA, Hall R, Fisher K, Haake SM, Khalil F, Schabath MB, Vuaroqueaux V, Fiebig HH, Altiok S, Chen YA, Haura EB.

Sci Signal. 2015 Jan 13;8(359):ra4. doi: 10.1126/scisignal.2005906.


Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.

Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK.

Eur Urol. 2012 Feb;61(2):258-68. doi: 10.1016/j.eururo.2011.10.007. Epub 2011 Oct 18.


Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms.

Van De Water TR, Abi Hachem RN, Dinh CT, Bas E, Haake SM, Hoosien G, Vivero R, Chan S, He J, Eshraghi AA, Angeli SI, Telischi FF, Balkany TJ.

Cochlear Implants Int. 2010 Jun;11 Suppl 1:42-55. doi: 10.1179/146701010X12671178390834.


Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling.

Haake SM, Dinh CT, Chen S, Eshraghi AA, Van De Water TR.

Hear Res. 2009 Sep;255(1-2):22-32. doi: 10.1016/j.heares.2009.05.003. Epub 2009 May 13.


Supplemental Content

Loading ...
Support Center